1. Hepcidin exerts a negative immunological effect in pulmonary tuberculosis without HIV co-infection, prolonging the time to culture-negative
- Author
-
Takeshi Kaneko, Makoto Kudo, Masaki Yamamoto, Ken Tashiro, Ryota Ushio, Nobuaki Kobayashi, and Takashi Sato
- Subjects
Adult ,Male ,0301 basic medicine ,Microbiology (medical) ,030106 microbiology ,HIV Infections ,Stimulation ,Jurkat cells ,lcsh:Infectious and parasitic diseases ,Sputum culture ,Mycobacterium tuberculosis ,03 medical and health sciences ,0302 clinical medicine ,Hepcidins ,Antigen ,Hepcidin ,hemic and lymphatic diseases ,medicine ,Humans ,Tuberculosis ,lcsh:RC109-216 ,Prospective Studies ,030212 general & internal medicine ,Tuberculosis, Pulmonary ,Phytohaemagglutinin ,medicine.diagnostic_test ,biology ,Coinfection ,business.industry ,Sputum ,nutritional and metabolic diseases ,HIV ,General Medicine ,Middle Aged ,biology.organism_classification ,Infectious Diseases ,Immunology ,biology.protein ,Female ,medicine.symptom ,business - Abstract
Objectives: A major regulatory peptide in iron metabolism, hepcidin, has been shown to predict mortality in HIV-infected tuberculosis patients. The aim of this study was to evaluate whether plasma hepcidin levels on admission can be used to predict the treatment outcome of patients with smear-positive pulmonary tuberculosis (PTB) without HIV co-infection. Methods: In this prospective observational study, a total of 35 PTB patients with Mycobacterium tuberculosis-positive sputum smears were enrolled. The relationship between plasma hepcidin levels on admission and the time period to sputum culture-negative was explored. Results: Plasma hepcidin levels of PTB patients were significantly higher than those of healthy subjects (p
- Published
- 2019